38 reports

  • Genetic Testing Market: Revenue in USD million, Diagnostic Testing, by Type,
  • Genetic Testing Market: Revenue in USD million, Diagnostic Testing, by Type,
  • Biopsy
  • World
  • Forecast
  • Cepheid
  • Transgenomic, Inc.

Genetic Testing Industry ## Chapter ##: Acquisitions and Strategic Alliances ## Acquisitions ## Strategic Alliances ## Trends ## 2016 Alliances ## 2017 Alliances ## Chapter ##: Liquid Biopsy Markets ## Growth Driving Forces ## Liquid Biopsy Market by Indication ## Liquid Biopsy Mar

  • Biopsy
  • Diagnostics
  • World
  • Forecast
  • Market Size
  • LIQUID BIOPSY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND
  • COMPETITIVE LANDSCAPE

Hence, therapies need to evolve constantly as the tumor undergoes genetic heterogeneity.

  • Biopsy
  • Market Size
  • American Cancer Society, Inc.
  • Biocept, Inc.
  • QIAGEN N.V.
  • GLOBAL BIOPSY DEVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • KEY FINDINGS

IN ADDITION, THIS TECHNIQUE AIDS IN CAPTURING THE ENTIRE GENETIC COMPLEXITY OF TUMORS AND HELPS IN LIMITING THE CHANCES OF CANCER CELLS SPREADING TO OTHER BODY PARTS.

  • Biopsy
  • Europe
  • World
  • Becton Property Group
  • Boston Scientific Corporation
  • Advantages of Liquid Biopsy in Screening Market
  • ii. Guide for Executives, Marketing, Sales and Business Development Staff

Vysis Vysis Vysis xDx Myriad Genetic Laboratories, Inc.

  • Biopsy
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.
  • Advantages of Liquid Biopsy in Screening Market
  • ii. Guide for Executives, Marketing, Sales and Business Development Staff

Vysis Vysis Vysis xDx Myriad Genetic Laboratories, Inc.

  • Biopsy
  • United States
  • Market Size
  • Illumina, Inc.
  • Trovagene, Inc.
  • NEOGENOMICS
  • SELECTED LIQUID BIOPSY TESTS BASED ON EXTRACELLULAR VESICLES/OTHER ANALYTES, 2017

CLARIENT WAS A LEADING LABORATORY IN PATHOLOGY TESTING SERVICES, AND ALSO OFFERED VARIOUS CANCER GENETIC TESTS.

  • Biopsy
  • World
  • Epigenomics AG
  • QIAGEN N.V.
  • Roche Group
  • OTHER PROMINENT VENDORS

It is a new entrant in the market, which develops liquid biopsy products based on genetic technology.

  • Biopsy
  • Biocept, Inc.
  • Exosome Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.

IDENTIFICATION OF SUCH GENETIC MATERIAL CAN HELP TO DETECT GENETIC EXPRESSION, WHICH HELPS TO DETECT DISEASES.

  • Biopsy
  • Genome Sequencing
  • Market Size
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.

SEEING THE IMPORTANCE OF RECOGNIZING INNOVATION IN ART TECHNOLOGIES, THE GLOBAL FERTILITY ALLIANCE WAS FOUNDED BY MERCK TOGETHER WITH TWO STRATEGIC PARTNERS: ILLUMINA, A LEADER IN DEVELOPING AND COMMERCIALIZING SYSTEMS FOR ANALYSIS OF GENETIC VARIATION AND FUNCTION, AND GENEA, A DEVELOPER O

  • Biopsy
  • Australia
  • Oceania
  • Forecast
  • Olympus Corporation
  • MARKET SIZE AND FORECAST
  • Market landscape

Develops liquid biopsy product based on genetic technology.

  • Biopsy
  • Biocept, Inc.
  • Exosome Diagnostics, Inc.
  • QIAGEN N.V.
  • Roche Group
  • ISET TEST
  • SELECTMDX

GENETIC TECHNOLOGIES ##.

  • Biopsy
  • United States
  • Market Size
  • Biocept, Inc.
  • Transgenomic, Inc.

Through the detection of different biomarkers, the diagnosis of cardiovascular diseases, infections, immunological and genetic disorders is certainly possible and opens new hopes for the patients.

  • Biopsy
  • Diagnostics
  • World
  • Market Size

The products profiled relate to all liquid biopsy strategies including circulating tumour cells, exosomes, circulating cell-free DNA (cfDNA), circulating cell-free tumour DNA (ctDNA) and other circulating genetic markers being explored in this field.

  • Biopsy
  • Diagnostics
  • 2.2 United States - Liquid Biopsy Screening Potential Market
  • United States - Liquid Biopsy Potential Market (Million US$), 2015 - 2020

As genetic research continues in the oncology space, associations between common mutations and tumor locations will be made.

  • Biopsy
  • United States
  • Forecast
  • Biocept, Inc.
  • Illumina, Inc.

Further key findings from the report suggest: In terms of applications, therapy selection of metastatic cancers is the key area of liquid biopsy usage as these provide significant insights into the unique genetic information encoded in CTCs and ctDNAs.

  • Biopsy
  • Diagnostics
  • Forecast

Genetic Test China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA) Global Cervical Cancer Screening Market & Patients, By T

  • Biopsy
  • United States
  • B. Braun Melsungen AG
  • Becton Property Group
  • Boston Scientific Corporation
  • 03/15/2016: NEW STUDY SHOWS THAT GENETIC INFORMATION FROM PROSTATE NEEDLE BIOPSY MAY BE USED TO PREDICT TUMOR AGGRESSIVENESS
  • Biopsy
  • Hospital
  • Prostate Cancer
  • United States
  • GenomeDx Biosciences Inc.
  • Apr 14, 2016: Transgenomic Reports Full Year 2015 Financial Results
  • May 24, 2016: Transgenomic Reports First Quarter 2016 Financial Results

It offers genetic assays and platforms such as PCR reagents, chromatography, genetic analysis kits, hanabi cytogenetic systems, tissue microarray platforms and WAVE DHPLC systems.

  • Biopsy
  • Pharmaceutical
  • United States
  • Company Financials
  • Transgenomic, Inc.
  • Function

Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization.

  • Biopsy
  • Clinical Trial
  • United States
  • Company
  • Biocept, Inc.
  • Dec 05, 2017: First U.S. Patent Issued for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Liquid Biopsy ctDNA Platform
  • SEP 09, 2016: BIOCEPT TO COLLABORATE WITH RENOWNED CLINICAL INVESTIGATOR DR. SHILPA GUPTA TO STUDY THE UTILITY OF LIQUID BIOPSY TESTING IN BLADDER AND PROSTATE CANCERS

This method greatly increases the detection sensitivity of genetic alterations such as cancer mutations in low abundance, as the " noise" associated with normal genetic sequences is largely eliminated.

  • Biopsy
  • United States
  • Company
  • Corporate Finance
  • Biocept, Inc.
  • Deal Type

Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization.

  • Biopsy
  • United States
  • Company
  • Corporate Finance
  • Biocept, Inc.
  • TROVERA EGFR CTDNA LIQUID BIOPSY TEST - PRODUCT DESCRIPTION
  • TROVERA BRAF CTDNA LIQUID BIOPSY TEST - PRODUCT DESCRIPTION

In Vitro Diagnostics--> Genetic Testing--> Acquired Gene or Chromosome Alterations Inactive TR-DNA BASED H.

  • Biopsy
  • DNA
  • Infectious Disease
  • United States
  • Trovagene, Inc.

IT IS DESIGNED TO DETECT THE GENETIC MUTATIONS SPECIFIC TO CANCER IN PATIENT' S SAMPLES.

  • Biopsy
  • Breast Cancer
  • Infectious Disease
  • Molecular Diagnostic
  • QIAGEN N.V.
  • Other Significant Developments Jun 03, 2017: Cure-One Announces Partnership with Guardant Health
  • Guardant Health Inc - Locations And Subsidiaries

Just ## of the ## patients in the study had at least one genetic mutation reported within the overlapping genetic sequences covered by both companies.

  • Biopsy
  • Cancer
  • United States
  • Company
  • GlobalData's company
  • IVLCM CAPSULE - PRODUCT DESCRIPTION
  • Biopsy
  • Clinical Trial
  • Hospital
  • United States
  • GlobalData's company
  • INIVATA LTD, RECENT DEVELOPMENTS

Commenting on the data, Geoffrey Oxnard, MD, thoracic oncologist and lung cancer researcher at Dana-Farber Cancer Institute, said, " These data show InVision is able to accurately deliver actionable information to clinicians about a range of genetic alterations and, in particular, its p

  • Biopsy
  • Cancer
  • Clinical Research
  • Clinical Trial
  • Lung Cancer
  • ISOFLUX CTC LIQUID BIOPSY SYSTEM - COLON CANCER - PRODUCT STATUS
  • ISOFLUX CTC LIQUID BIOPSY SYSTEM - LUNG CANCER - PRODUCT STATUS
  • Biopsy
  • Cancer
  • United States
  • Product Initiative
  • GlobalData's company

HE IS BOTH A LICENSED AND CERTIFIED GENETIC COUNSELOR.

  • Biopsy
  • Body Contouring Device
  • North America
  • United States
  • Forecast